# TB500 Dosage: Why There Is No Set Dose and How Providers Decide

**By TelosRX Editorial Team** · 2026-10-29

**There is no established human TB500 dosage. TB-500 has never completed a clinical trial in people, the FDA says it has identified no human exposure data for it, and the numbers you see online come from forums, vendor charts and animal work, not from dose-finding studies. If a dose is used at all, it should be set by a licensed provider for you, not copied from a chart.**

That answer frustrates a lot of people, because searching "tb500 dosage" returns pages of confident numbers, loading phases and weekly schedules. This guide explains where those numbers come from, why they are not a reliable basis for anyone's TB500 dose, and what a provider actually weighs when setting a protocol. Note that telos rx does not offer TB-500 on its own. It is only prescribed as part of the [BPC-157 + TB-500 stack](https://www.telosrx.com/pages/bpc-157-tb500), after provider review.

Also searched as: tb 500 dosage, tb-500 dosage, tb500 dose and tb500 dosing.

## Why there is no established TB500 dosage for humans

A real dose for any medicine comes from a sequence of studies. Researchers first test safety across a range of doses, then compare doses against a placebo for a specific condition, then confirm the best one in larger trials. That process is what produces a label with a number on it. TB-500 has not been through it.

TB-500 is a synthetic peptide based on the actin-binding region of thymosin beta-4 (Tβ4), a 43-amino-acid protein found in most human cells. Tβ4 binds and holds single actin molecules (G-actin), which helps regulate how cells build their internal scaffolding and move. That role was described in a [1991 paper by Safer and colleagues](https://pubmed.ncbi.nlm.nih.gov/1999398/), which showed Tβ4 forms a 1:1 complex with actin monomers. TB-500 is a fragment or analog of that protein, not the full molecule.

In its list of bulk substances that may present significant safety risks in compounding, the [FDA notes](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks) that it has not identified any human exposure data for thymosin beta-4 fragment (LKKTETQ), the sequence also known as TB-500. With no human exposure data, there is nothing from which to derive a human TB500 dosage. TB-500 is not FDA-approved for any use.

Want a professional to make the dosing decision? A licensed provider reviews your online intake asynchronously and decides whether the BPC-157 + TB-500 stack fits your history. telos rx does not offer TB-500 on its own.

[See if the BPC-157 + TB-500 stack is right for you](https://www.telosrx.com/pages/bpc-157-tb500)

## What the online "TB500 loading dose" framing claims

Most TB500 dosage pages follow one template. They describe a "loading" phase, where the peptide is injected more often at the start, followed by a "maintenance" phase with less frequent injections, sometimes for months. Some add a total cycle length and a rest period. The TB500 loading dose is usually presented as a fixed milligram figure, as if it came from a trial.

Be precise about what that framing is. It is a claim, repeated across forums, vendor charts and some clinic write-ups. It is not a regimen tested in a controlled human study of TB-500. We describe it here so you can recognise it, not so you can follow it, and we are deliberately not reproducing the numbers.

The loading and maintenance idea is borrowed from medicines that genuinely use it, where a higher first dose brings blood levels up quickly. For those drugs, the schedule rests on measured pharmacokinetics in people: how fast the drug is absorbed, how long it lasts and how it is cleared. For TB-500, those human measurements have not been published, so the TB500 loading dose concept, and any TB500 dosage built on it, has nothing underneath it.

## Why common TB500 dose charts are unreliable

There are specific reasons a chart-based TB500 dosage is a poor guide.

| Problem with chart doses | Why it matters |
| --- | --- |
| **Different molecule** | The best human safety data are on full-length synthetic Tβ4, not the TB-500 fragment, so they cannot simply be transferred. |
| **Different route** | That human study gave Tβ4 by intravenous infusion. Most TB500 dosing advice assumes a small injection under the skin. |
| **Animal scaling** | Many figures trace back to rodent or veterinary use. Converting an animal dose to a person is not a straight weight calculation. |
| **Unknown vial contents** | Grey-market "research use only" vials are not made for human use. The labelled amount may not match what is inside. |
| **No outcome measured** | A chart cannot tell you what dose, if any, does anything for a specific person or condition. |

The intravenous study mentioned above is worth understanding properly. [Ruff and colleagues (2010)](https://pubmed.ncbi.nlm.nih.gov/20536472/) gave healthy volunteers synthetic Tβ4 by IV, first as single doses and then daily for 14 days, in four ascending cohorts ranging from 42 to 1,260 mg. Adverse events were infrequent and mild or moderate, with no dose-limiting toxicity. That is a research protocol for a different molecule, given into a vein, in a study designed to check tolerability, not benefit. It is not a TB-500 dosage, and it should never be read as a TB500 dose for anyone.

The vial problem is just as serious. If the contents are uncertain, any TB500 dosage figure is uncertain too, however carefully it is measured. That is one reason we recommend reading [how to read a peptide certificate of analysis](https://www.telosrx.com/blogs/peptides/how-to-read-a-peptide-coa) before trusting any label.

Skip the chart guesswork. A prescription from a licensed provider, compounded by a licensed US pharmacy, replaces a vendor's dosing table with a protocol set for you. Every prescription is subject to medical approval by a licensed provider.

[Start your provider review](https://www.telosrx.com/pages/bpc-157-tb500)

## How a provider sets a stack protocol instead of a TB500 dosage chart

When a provider considers TB-500, the starting question is not "what is the TB500 dosage?" It is "is this appropriate for this person at all?" At telos rx, TB-500 is only prescribed within the BPC-157 + TB-500 stack, as one provider-set protocol covering two separate vials. Here is the general sequence.

1.  **Online intake.** You complete a health questionnaire covering your goals, medical history, current medications and any cancer history. It is reviewed asynchronously, with no scheduled appointment.
2.  **Screening for reasons to say no.** Because Tβ4 is studied for angiogenesis (new blood vessel growth), people with cancer or a cancer history are commonly advised to avoid it. The stack is not for pregnancy or breastfeeding, and tested athletes are flagged for anti-doping rules.
3.  **A protocol decision.** If the provider approves, they set the dose, frequency and duration of the stack for you. Approval is not guaranteed. See the [BPC-157 + TB-500 stack page](https://www.telosrx.com/pages/bpc-157-tb500) for how plans work.
4.  **Compounding and labelling.** A licensed US pharmacy prepares the stack, and your instructions come from your prescriber, not a chart.
5.  **Follow-up.** Secure messaging with the care team lets you report side effects or changes, and the provider can adjust, pause or stop the protocol.

This is the practical difference between a provider-set protocol and a downloaded TB500 dosage table. The provider can decline, can account for your medications and history, and stays responsible for the decision. For the stack itself, see our sibling guides on [Wolverine stack dosage protocols](https://www.telosrx.com/blogs/peptides/wolverine-stack-dosage-protocol) and [how much BPC-157 and TB-500 to take](https://www.telosrx.com/blogs/peptides/how-much-bpc-157-and-tb-500-to-take), plus the longer explainer on the [Wolverine peptide stack](https://www.telosrx.com/blogs/peptides/wolverine-peptide-stack-bpc-157-tb-500-explained).

## What affects a provider's TB500 dosage decision

Because there is no reference TB500 dosage to start from, a provider leans on the factors they can actually assess:

-   **Your health history**, especially cancer history, cardiovascular conditions and any bleeding or clotting issues.
-   **Current medications and supplements**, which may change the risk picture.
-   **What you are hoping to address**, and whether a peptide with almost no human data is a reasonable option for it.
-   **Prior reactions** to injections or peptides, including injection-site reactions.
-   **Sport and testing**, since TB-500 is prohibited by WADA at all times.

Side effects that have been reported or theorised include injection-site reactions, headache, nausea, dizziness, fatigue and flushing. Long-term human safety is not established. Our [TB-500 side effects guide](https://www.telosrx.com/blogs/peptides/tb-500-side-effects-7-things-to-know) covers these in more detail, and [our TB-500 tissue repair research overview](https://www.telosrx.com/blogs/peptides/tb-500-peptide-tissue-repair-research) covers what the animal studies examined.

## TB500 dosage, sport and the law

Two more points shape any TB500 dosage conversation. First, sport: both TB-500 and BPC-157 are on the WADA Prohibited List at all times, under S0 (non-approved substances), and TB-500 is also covered by S2 (peptide hormones, growth factors and related substances). A prescription does not change that, so tested athletes should not use them. Our [WADA and drug testing guide](https://www.telosrx.com/blogs/peptides/bpc-157-wada-status-athletes-drug-testing) explains more.

Second, regulation. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted to recommend adding TB-500 and BPC-157 to the list of bulk substances that can be used in compounding, pending FDA rulemaking. The vote is advisory and non-binding, and FDA's own briefing documents had recommended against. On October 28, 2026, HHS announced a temporary enforcement discretion policy that covers TB-500 as a single-ingredient subcutaneous or intramuscular injection compounded by state-licensed pharmacies, under strict sourcing, testing and reporting conditions; it does not cover blends that combine TB-500 with another peptide in one product ([Federal Register notice](https://www.federalregister.gov/d/2026-22192)). The telos rx stack is supplied as two separate vials, so neither vial is a blend. It is not FDA approval, and HHS can revisit it. The full picture is in our [TB-500 regulatory status update](https://www.telosrx.com/blogs/peptides/tb-500-regulatory-status-after-pcac-vote).

If you want to understand how long a protocol typically runs before a provider reassesses, see our upcoming guide to [TB-500 cycle length](https://www.telosrx.com/blogs/peptides/tb-500-cycle-length-explained), and for questions about timing, [how long TB-500 takes to work](https://www.telosrx.com/blogs/peptides/how-long-does-tb-500-take-to-work).

## TB500 dosage: frequently asked questions

### What is the correct TB500 dosage?

There is no established correct TB500 dosage for humans. TB-500 has not completed clinical trials in people, and the FDA says it has identified no human exposure data for it. Any dose should be set by a licensed provider after reviewing your history.

### What is a TB500 loading dose?

A TB500 loading dose is a claim found on forums and vendor charts: inject more often at first, then less often for maintenance. It is borrowed from medicines with measured human pharmacokinetics. For TB-500 those measurements have not been published, so the claim is not evidence-based.

### Is TB500 dosing the same as thymosin beta-4 dosing?

No. TB-500 is a fragment or analog of thymosin beta-4, not the full protein. The best human safety study used full-length synthetic thymosin beta-4 given intravenously, so its doses cannot be transferred to a TB-500 injection under the skin.

### Why do TB 500 dosage charts disagree with each other?

Because none of them come from human dose-finding trials. They mix forum reports, animal and veterinary figures and vendor guesswork, and vial contents from grey-market sellers are unverified. Disagreement between charts is a sign that no reliable reference TB500 dosage exists.

### Can I get a TB-500 dosage prescribed by telos rx?

telos rx does not offer TB-500 on its own. It is only prescribed as part of the BPC-157 + TB-500 stack, where a licensed provider sets one protocol covering two separate vials for you after an asynchronous online review. Every prescription is subject to medical approval by a licensed provider.

### Who should avoid TB-500 regardless of TB500 dosage?

People with cancer or a cancer history are commonly advised to avoid it because thymosin beta-4 is studied for angiogenesis. It is not for pregnancy or breastfeeding, and tested athletes should not use it because WADA prohibits it at all times. A provider makes the final decision.

### Is TB-500 FDA-approved?

No. TB-500 is not FDA-approved for any use. In July 2026 an FDA advisory committee voted to recommend adding it to the list of bulk substances usable in compounding, pending FDA rulemaking. That vote is non-binding. An October 28, 2026 HHS interim enforcement discretion policy covers single-ingredient TB-500 injections under strict conditions while rulemaking continues, which is also not FDA approval.

Ready for a provider to look at your history? Complete a short online intake and a licensed provider will decide whether the BPC-157 + TB-500 stack is appropriate, from $133 per month if approved. Plans can be paused or cancelled.

[See if the BPC-157 + TB-500 stack is right for you](https://www.telosrx.com/pages/bpc-157-tb500)

_This article is for general education and is not medical advice. TB-500 is not FDA-approved, and BPC-157 is not FDA-approved, for any use. There is no established human TB-500 dose, and nothing here is a dosing recommendation. telos rx does not offer TB-500 on its own; it is prescribed only as part of the compounded BPC-157 + TB-500 stack, subject to medical approval by a licensed provider. Approval is not guaranteed. telos rx is an online, asynchronous telehealth service, and prescriptions are compounded by a licensed US pharmacy. Both peptides are prohibited in sport by WADA._

**Tags:** BPC-157, peptide dosing, provider review, TB-500, TB-500 dosage, tb500 dosage, tb500 dosing, Wolverine Stack

---

> Source: [Telos RX](https://www.telosrx.com/blogs/peptides/tb-500-dosage-how-providers-dose)
